Mezquita, L., Ferriol-Galmes, M., Albarran-Artahona, V., Gorria, T., Laguna, J. C., Rota, M., Montes, A., Anguita, D., Jimenez, M., Janin, M., Arcocha, A., Bakkali, J., Mena, J., Teixido, C., Besse, B., Dingemans, A. C., Auclin, Ã. (2026). ALFA score as a predictor of long-term benefit with frontline brigatinib in
                    <i>ALK</i>
                    + advanced NSCLC: A ctDNA-based composite biomarker from ALTA-1L.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8646